Cargando…

Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies

Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Heydari, Zahra, Najimi, Mustapha, Mirzaei, Hamed, Shpichka, Anastasia, Ruoss, Marc, Farzaneh, Zahra, Montazeri, Leila, Piryaei, Abbas, Timashev, Peter, Gramignoli, Roberto, Nussler, Andreas, Baharvand, Hossein, Vosough, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072533/
https://www.ncbi.nlm.nih.gov/pubmed/32012725
http://dx.doi.org/10.3390/cells9020304
_version_ 1783506428589244416
author Heydari, Zahra
Najimi, Mustapha
Mirzaei, Hamed
Shpichka, Anastasia
Ruoss, Marc
Farzaneh, Zahra
Montazeri, Leila
Piryaei, Abbas
Timashev, Peter
Gramignoli, Roberto
Nussler, Andreas
Baharvand, Hossein
Vosough, Massoud
author_facet Heydari, Zahra
Najimi, Mustapha
Mirzaei, Hamed
Shpichka, Anastasia
Ruoss, Marc
Farzaneh, Zahra
Montazeri, Leila
Piryaei, Abbas
Timashev, Peter
Gramignoli, Roberto
Nussler, Andreas
Baharvand, Hossein
Vosough, Massoud
author_sort Heydari, Zahra
collection PubMed
description Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, heart, skin, and kidney. Liver tissue engineering (TE) enables us to reproduce and restore liver functions, fully or partially, which could be used in the treatment of acute or chronic liver disorders and/or generate an appropriate functional organ which can be transplanted or employed as an extracorporeal device. In this regard, a variety of techniques (e.g., fabrication technologies, cell-based technologies, microfluidic systems and, extracorporeal liver devices) could be applied in tissue engineering in liver regenerative medicine. Common TE techniques are based on allocating stem cell-derived hepatocyte-like cells or primary hepatocytes within a three-dimensional structure which leads to the improvement of their survival rate and functional phenotype. Taken together, new findings indicated that developing liver tissue engineering-based techniques could pave the way for better treatment of liver-related disorders. Herein, we summarized novel technologies used in liver regenerative medicine and their future applications in clinical settings.
format Online
Article
Text
id pubmed-7072533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70725332020-03-19 Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies Heydari, Zahra Najimi, Mustapha Mirzaei, Hamed Shpichka, Anastasia Ruoss, Marc Farzaneh, Zahra Montazeri, Leila Piryaei, Abbas Timashev, Peter Gramignoli, Roberto Nussler, Andreas Baharvand, Hossein Vosough, Massoud Cells Review Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, heart, skin, and kidney. Liver tissue engineering (TE) enables us to reproduce and restore liver functions, fully or partially, which could be used in the treatment of acute or chronic liver disorders and/or generate an appropriate functional organ which can be transplanted or employed as an extracorporeal device. In this regard, a variety of techniques (e.g., fabrication technologies, cell-based technologies, microfluidic systems and, extracorporeal liver devices) could be applied in tissue engineering in liver regenerative medicine. Common TE techniques are based on allocating stem cell-derived hepatocyte-like cells or primary hepatocytes within a three-dimensional structure which leads to the improvement of their survival rate and functional phenotype. Taken together, new findings indicated that developing liver tissue engineering-based techniques could pave the way for better treatment of liver-related disorders. Herein, we summarized novel technologies used in liver regenerative medicine and their future applications in clinical settings. MDPI 2020-01-27 /pmc/articles/PMC7072533/ /pubmed/32012725 http://dx.doi.org/10.3390/cells9020304 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Heydari, Zahra
Najimi, Mustapha
Mirzaei, Hamed
Shpichka, Anastasia
Ruoss, Marc
Farzaneh, Zahra
Montazeri, Leila
Piryaei, Abbas
Timashev, Peter
Gramignoli, Roberto
Nussler, Andreas
Baharvand, Hossein
Vosough, Massoud
Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title_full Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title_fullStr Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title_full_unstemmed Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title_short Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
title_sort tissue engineering in liver regenerative medicine: insights into novel translational technologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072533/
https://www.ncbi.nlm.nih.gov/pubmed/32012725
http://dx.doi.org/10.3390/cells9020304
work_keys_str_mv AT heydarizahra tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT najimimustapha tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT mirzaeihamed tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT shpichkaanastasia tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT ruossmarc tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT farzanehzahra tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT montazerileila tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT piryaeiabbas tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT timashevpeter tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT gramignoliroberto tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT nusslerandreas tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT baharvandhossein tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies
AT vosoughmassoud tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies